COVID-19

Navigating Together for a Better Tomorrow


How Quasar Is Responding to COVID-19 and Its Effect On Businesses

As the coronavirus pandemic continues to change the world, we’re all navigating through uncertainty. 

At Quasar, we embrace our “philosophy of operational excellence”. This means that even in times of struggle, we have an operational focused effort. While our number one concern is the health and safety of our employees and our community, we are also here to assist you with business continuity, even in these uncertain times.

Covid-19 resilience

How We're Helping

Meeting all Q-2 commitments and more.

We are here to support the medical device companies globally who have been affected by the pandemic and thus facing challenges to meet previously set production goals. To ensure we are in a position to to support your production needs, we have EXPANDED Manufacturing Capacity in the following areas:

ISO/FDA Registered Facilities

+30k sqft ISO 7/8 Clean Rooms at our ISO/FDA Registered Facilities in China, Hong Kong, and Thailand.

Fully staffed

with additional capacity to support Class II & III devices.

Critical Backorders recovery plan

Commercial and Manufacturing teams at the ready to assist with evaluating and developing a recovery plan for you.

Second Source

Commercial, Quality and Supply Chain teams at the ready to assist with your supplier qualification and approval process to qualify a second source.

Manufacturing Transfers

Commercial, Quality and Engineering teams at the ready to assist with validation and transfer plans to support a manufacturing transfer project.

Emergency Action Plans

Quasar can assist with developing an emergency (mitigation) action plan to avoid future disruptions to your supply chain.

CONTACT US


COVID-19 Resources

China MAH Policy

China MAH Policy Changes and The massive Opportunity for Medical Device OEMs

The new MAH or Marketing Authorization Holder Policy has opened up a whole new level of opportunities for medical device companies. OEMs must capitalize on the major changes taking place in the Chinese market in allowing high-quality medical devices to be manufactured and marketed without as many restrictions as they experienced prior to the MAH Policy.

Embolization Coiling

Embolization Coiling: The Importance of Material selection

Embolization coiling is a minimally invasive catheter-based procedure that employs a coil that can cause an occlusion. What’s important... read more

China MAH Policy

China MAH Policy Changes and The massive Opportunity for Medical Device OEMs

The new MAH or Marketing Authorization Holder Policy has opened up a whole new level of opportunities for medical... read more

Medical Device Prototyping

Optimal Medical Device Prototyping for Getting to Market Sooner

If these core elements are not carefully assessed, planned and tested through prototyping, the problems arising at the FDA... read more